10/21/2024CDE Solicits Comments on the Scope and Procedures for Filing Bioequiva...

10/21/2024China Releases First National Guidelines for Obesity Diagnosis and Tre...

10/21/2024China Sees Drop in Deaths from Chronic Diseases as Efforts Intensify A...

10/21/2024CStone Announces Patent Publication for First-in-Class ADC CS5006

10/21/2024USFDA Grants Fast Track Designation to Coherent Biopharma's CBP-1008

10/21/2024Europe's Share of Global Clinical Trials Shrinks as China Gains Ground...

10/21/2024NMPA Issues the Pilot Plan for Staged Production of Biological Product...

10/21/2024Clinical Benefit, Price, and Regulatory Approval of Cancer Drugs Grant...

10/21/2024Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...

10/18/2024AstraZeneca Submits Marketing Applications for Tremelimumab and Durval...

10/18/2024AsiFlyer Secures CNY Tens of Mlns in Series Pre-A+ Financing to Advanc...

10/18/2024LaNova Medicines Secures CNY 300M in Series C1 Financing to Advance On...

10/18/2024NMPA Launches Pilot Reform for Staged Production of Biologicals

10/18/2024CDE Solicits Comments on the Technical Guidelines for Clinical Risk Ma...

10/18/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (87...

10/18/2024Recent Executive Moves

10/17/2024Novartis, Chengdu Baiyu in Licensing Deal for Latter's Tumor Small Mol...

10/17/2024MSD Files NDA for WINREVAIR (sotatercept) in China

10/17/2024Portal Biotech Secures Multi-Million RMB Angel Financing

10/17/2024Gan & Lee Achieves Primary Endpoints in Phase 2 Trials of Three Diabet...

10/17/2024China Initiates Data Collection for the 10th Round of the National Lev...

10/17/2024Hutchmed Announces Positive Results from Phase II SAVANNAH Trial for L...

10/17/2024NMPA Holds National Drug Distribution Supervision Work Conference

10/16/2024Eli Lilly Expands Innovation Centers to Beijing with New Research Faci...

10/16/2024TenNor Announces CNY 300M+ Financing to Support Development and Comme...

10/16/2024Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...

10/16/2024Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab

10/16/2024GSK's Submits Priority Review Application for BCMA ADC in China

10/16/2024Akeso Launches Phase 1/2 Trial of AK129 and AK117

10/16/2024Hengrui Medicine Launches Phase 1/2 Trial for Nectin-4 ADC SHR-A2102 i...

Page:56/786 Total number of articles:23558: [First][<<] [54] [55] [56] [57] [58] [>>] [End]